en.sedaily.com
Cure8 news brief
Crohn's Disease Cases Double in Korea, Half Under 40 - Seoul Economic Daily
Community and awareness
Abdominal Pain
Diarrhea
Fever
Weight Loss
Flare
Clinical study
Adult patients
Why This Matters
Crohn’s disease prevalence and new diagnoses are rising rapidly in Korea, especially among people in their 20s and 30s; that affects demand for diagnosis, long-term care, and affordable treatment.
The regional analysis links increases to Westernized diets and environmental changes, which may be relevant to prevention and health policy planning.
Who Should Pay Attention
People with Crohn’s or IBD (especially young adults and newly diagnosed), caregivers, gastroenterologists and clinicians, health-system planners, and researchers in IBD epidemiology and environmental risk factors.
Study Snapshot
Story typeMainstream News
Evidence typeClinical study
Source depthFull source text
What To Know
A Korean health-data report cited by the article found 33,238 patients sought hospital treatment for Crohn’s disease in 2023 versus 16,138 in 2013, and young adults made up the largest share (20s and 30s).
The piece highlights that Crohn’s can affect any part of the digestive tract and that many patients require long-term management; it notes a public figure who underwent surgery removing about 60 cm of small intestine as an example of surgical treatment for complications such as stricturing.
The article summarizes a regional analysis led by a Korean gastroenterology team (published in The Lancet Gastroenterology & Hepatology) that describes four stages of IBD spread in Asia and links rising prevalence to Westernized diets, improved sanitation, early-life antibiotic exposure, and other environmental shifts.
The researchers recommend strengthening early-diagnosis infrastructure, multidisciplinary care, life-stage–tailored treatment, and policies to address the cost of expensive therapies including biologics.
Keep In Mind
The story reports national health-service treatment counts and summarizes a published Lancet Gastroenterology & Hepatology analysis; it is a synthesis of epidemiologic trends and expert recommendations, not a report of a new clinical trial or individual patient-level research findings.
Source Details
Review the original publication for the complete reporting, methods, and context.
Publicationen.sedaily.com
Indexed viaGoogle News
Source typeWeb article
PublishedSep 21, 2026, 9:32 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
How to Care for Someone With Crohn’s Disease
Caregivers play a key role in day-to-day management of Crohn’s — from tracking triggers and appointments to offering emotional support. Practical caregiving steps can help reduce symptom burden and improve quality of...
Crohn's Disease Market Analysis 2034: Clinical Trials, EMA, - openPR.com
The article summarizes a commercial market report that lists current and upcoming Crohn's disease treatments, trial results, and a biosimilar approval — information patients may see reflected in treatment availability,...
How does Crohn's disease affect your cancer risk? | Nebraska Medicine Omaha, NE
Chronic inflammation in Crohn’s, especially when the colon is affected, raises colorectal cancer risk over time. Knowing risk factors and recommended screening helps people with Crohn’s get earlier detection and...